Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance

PURPOSE: Approximately 15% to 20% of our patients with head and neck cancer receiving neoadjuvant chemotherapy (NACT) discontinue therapy because of various nonmedical reasons. We sought to analyze the factors associated with treatment default and noncompliance among these patients. PATIENTS AND MET...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Glob Oncol
Egile Nagusiak: Patil, Vijay M., Noronha, Vanita, Joshi, Amit, Muddu, Vamshi, Dhumal, Sachin, Bhattacharjee, Atanu, Prabhash, Kumar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2015
Gaiak:
ORIGINAL REPORTS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5539870/
https://ncbi.nlm.nih.gov/pubmed/28804775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.2015.000265
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak